Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YA-101 in Multiple System Atrophy
NCT06848231Phase 2Active, not recruiting
- Sponsor
- Dasher Neuroscience
- Start
- Mar 2025
- Primary completion
- Jun 2027
- Countries
- 3
01
Overview
A Phase 2 trial of YA-101 in multiple system atrophy (MSA), sponsored by Dasher Neuroscience. Started Mar 2025; status: active, not recruiting.
02
Drugs
YA-101
03
Conditions
multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT06848231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06848231.